Industry Research Reports

Home > Reports > Pharma & Healthcare > Global and United States Diabetes Medicines Market Report & Forecast 2024-2030

Global and United States Diabetes Medicines Market Report & Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-05-17

Pages: 143 Pages

Report ld: 2657397

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Medicines revenue was US$ 97410 million in 2023 and is forecast to a readjusted size of US$ 207020 million by 2030 with a CAGR of 11.2% during the review period (2024-2030).

Diabetes Medicines Market Size

M= millions and B=billions

In United States the Diabetes Medicines revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Diabetes Medicines market, also covers the segmentation data of other regions in regional level and county level.

Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%. 
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

Diabetes Medicines market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Diabetes Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Diabetes Medicines market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation

Report Metric
Details
Report Title
Global and United States Diabetes Medicines Market Report & Forecast 2024-2030
Forecasted Market Size in 2030
US$ 207020 million
CAGR(2024-2030)
11.2%
Market Size Available for Years
2019-2030
Global Diabetes Medicines Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Medicines Market, Segment by Type
Oral

Injection
Global Diabetes Medicines Market, Segment by Application
Hospital

Retail Pharmacy
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces Diabetes Medicines definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Diabetes Medicines companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Diabetes Medicines in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Diabetes Medicines sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion

Table of Contents

 1 Study Coverage
    1.1 Diabetes Medicines Product Introduction
    1.2 Global Diabetes Medicines Outlook 2019 VS 2023 VS 2030
        1.2.1 Global Diabetes Medicines Sales in US$ Million for the Year 2019-2030
        1.2.2 Global Diabetes Medicines Sales in Volume for the Year 2019-2030
    1.3 United States Diabetes Medicines Outlook 2019 VS 2023 VS 2030
        1.3.1 United States Diabetes Medicines Sales in US$ Million for the Year 2019-2030
        1.3.2 United States Diabetes Medicines Sales in Volume for the Year 2019-2030
    1.4 Diabetes Medicines Market Size, United States VS Global, 2019 VS 2023 VS 2030
        1.4.1 The Market Share of United States Diabetes Medicines in Global, 2019 VS 2023 VS 2030
        1.4.2 The Growth Rate of Diabetes Medicines Market Size, United States VS Global, 2019 VS 2023 VS 2030
    1.5 Diabetes Medicines Market Dynamics
        1.5.1 Diabetes Medicines Industry Trends
        1.5.2 Diabetes Medicines Market Drivers
        1.5.3 Diabetes Medicines Market Challenges
        1.5.4 Diabetes Medicines Market Restraints
    1.6 Assumptions and Limitations
    1.7 Study Objectives
    1.8 Years Considered

 2 Diabetes Medicines by Type
    2.1 Diabetes Medicines Market by Type
        2.1.1 Oral
        2.1.2 Injection
    2.2 Global Diabetes Medicines Market Size by Type
        2.2.1 Global Diabetes Medicines Sales in Value, by Type (2019, 2023 & 2030)
        2.2.2 Global Diabetes Medicines Sales in Volume, by Type (2019, 2023 & 2030)
        2.2.3 Global Diabetes Medicines Average Selling Price (ASP) by Type (2019, 2023 & 2030)
    2.3 United States Diabetes Medicines Market Size by Type
        2.3.1 United States Diabetes Medicines Sales in Value, by Type (2019, 2023 & 2030)
        2.3.2 United States Diabetes Medicines Sales in Volume, by Type (2019, 2023 & 2030)
        2.3.3 United States Diabetes Medicines Average Selling Price (ASP) by Type (2019, 2023 & 2030)

 3 Diabetes Medicines by Application
    3.1 Diabetes Medicines Market by Application
        3.1.1 Hospital
        3.1.2 Retail Pharmacy
    3.2 Global Diabetes Medicines Market Size by Application
        3.2.1 Global Diabetes Medicines Sales in Value, by Application (2019, 2023 & 2030)
        3.2.2 Global Diabetes Medicines Sales in Volume, by Application (2019, 2023 & 2030)
        3.2.3 Global Diabetes Medicines Average Selling Price (ASP) by Application (2019, 2023 & 2030)
    3.3 United States Diabetes Medicines Market Size by Application
        3.3.1 United States Diabetes Medicines Sales in Value, by Application (2019, 2023 & 2030)
        3.3.2 United States Diabetes Medicines Sales in Volume, by Application (2019, 2023 & 2030)
        3.3.3 United States Diabetes Medicines Average Selling Price (ASP) by Application (2019, 2023 & 2030)

 4 Global Diabetes Medicines Competitor Landscape by Company
    4.1 Global Diabetes Medicines Market Size by Company
        4.1.1 Global Key Manufacturers of Diabetes Medicines, Ranked by Revenue (2023)
        4.1.2 Global Diabetes Medicines Revenue by Manufacturer (2019-2024)
        4.1.3 Global Diabetes Medicines Sales by Manufacturer (2019-2024)
        4.1.4 Global Diabetes Medicines Price by Manufacturer (2019-2024)
    4.2 Global Diabetes Medicines Concentration Ratio (CR)
        4.2.1 Diabetes Medicines Market Concentration Ratio (CR) (2019-2024)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Diabetes Medicines in 2023
        4.2.3 Global Diabetes Medicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Key Manufacturers of Diabetes Medicines, Manufacturing Base Distribution and Headquarters
    4.4 Global Key Manufacturers of Diabetes Medicines, Product Offered and Application
    4.5 Global Key Manufacturers of Diabetes Medicines, Date of Enter into This Industry
    4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.7 United States Diabetes Medicines Market Size by Company
        4.7.1 Key Players of Diabetes Medicines in United States, Ranked by Revenue (2023)
        4.7.2 United States Diabetes Medicines Revenue by Players (2019-2024)
        4.7.3 United States Diabetes Medicines Sales by Players (2019-2024)

 5 Global Diabetes Medicines Market Size by Region
    5.1 Global Diabetes Medicines Market Size by Region: 2019 VS 2023 VS 2030
    5.2 Global Diabetes Medicines Market Size in Volume by Region (2019-2030)
        5.2.1 Global Diabetes Medicines Sales in Volume by Region: 2019-2024
        5.2.2 Global Diabetes Medicines Sales in Volume Forecast by Region (2025-2030)
    5.3 Global Diabetes Medicines Market Size in Value by Region (2019-2030)
        5.3.1 Global Diabetes Medicines Sales in Value by Region: 2019-2024
        5.3.2 Global Diabetes Medicines Sales in Value by Region: 2025-2030

 6 Americas
    6.1 Americas Diabetes Medicines Market Size YoY Growth 2019-2030
    6.2 Americas Diabetes Medicines Sales in Volume, by Type (2019, 2023 & 2030)
    6.3 Americas Diabetes Medicines Sales in Volume, by Application (2019, 2023 & 2030)
    6.4 Americas Diabetes Medicines Market Facts & Figures by Country (2019, 2023 & 2030)
        6.4.1 Americas Diabetes Medicines Sales in Value by Country (2019, 2023 & 2030)
        6.4.2 Americas Diabetes Medicines Sales in Volume by Country (2019, 2023 & 2030)
        6.4.3 United States
        6.4.4 Canada
        6.4.5 Mexico
        6.4.6 Brazil

 7 EMEA
    7.1 EMEA Diabetes Medicines Market Size YoY Growth 2019-2030
    7.2 EMEA Diabetes Medicines Sales in Volume, by Type (2019, 2023 & 2030)
    7.3 EMEA Diabetes Medicines Sales in Volume, by Application (2019, 2023 & 2030)
    7.4 EMEA Diabetes Medicines Market Facts & Figures by Country (2019, 2023 & 2030)
        7.4.1 EMEA Diabetes Medicines Sales in Value by Country (2019, 2023 & 2030)
        7.4.2 EMEA Diabetes Medicines Sales in Volume by Country (2019, 2023 & 2030)
        7.4.3 Europe
        7.4.4 Middle East
        7.4.5 Africa

 8 China
    8.1 China Diabetes Medicines Market Size YoY Growth 2019-2030
    8.2 China Diabetes Medicines Sales in Volume, by Type (2019, 2023 & 2030)
    8.3 China Diabetes Medicines Sales in Volume, by Application (2019, 2023 & 2030)

 9 APAC
    9.1 APAC Diabetes Medicines Market Size YoY Growth 2019-2030
    9.2 APAC Diabetes Medicines Sales in Volume, by Type (2019, 2023 & 2030)
    9.3 APAC Diabetes Medicines Sales in Volume, by Application (2019, 2023 & 2030)
    9.4 APAC Diabetes Medicines Market Facts & Figures by Country (2019, 2023 & 2030)
        9.4.1 APAC Diabetes Medicines Sales in Value by Country (2019, 2023 & 2030)
        9.4.2 APAC Diabetes Medicines Sales in Volume by Country (2019, 2023 & 2030)
        9.4.3 Japan
        9.4.4 South Korea
        9.4.5 China Taiwan
        9.4.6 Southeast Asia
        9.4.7 India

 10 Company Profiles
    10.1 Novo Nordisk
        10.1.1 Novo Nordisk Company Information
        10.1.2 Novo Nordisk Description and Business Overview
        10.1.3 Novo Nordisk Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.1.4 Novo Nordisk Diabetes Medicines Products Offered
        10.1.5 Novo Nordisk Recent Development
    10.2 Sanofi
        10.2.1 Sanofi Company Information
        10.2.2 Sanofi Description and Business Overview
        10.2.3 Sanofi Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.2.4 Sanofi Diabetes Medicines Products Offered
        10.2.5 Sanofi Recent Development
    10.3 Eli Lilly
        10.3.1 Eli Lilly Company Information
        10.3.2 Eli Lilly Description and Business Overview
        10.3.3 Eli Lilly Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.3.4 Eli Lilly Diabetes Medicines Products Offered
        10.3.5 Eli Lilly Recent Development
    10.4 Merck
        10.4.1 Merck Company Information
        10.4.2 Merck Description and Business Overview
        10.4.3 Merck Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.4.4 Merck Diabetes Medicines Products Offered
        10.4.5 Merck Recent Development
    10.5 AstraZeneca
        10.5.1 AstraZeneca Company Information
        10.5.2 AstraZeneca Description and Business Overview
        10.5.3 AstraZeneca Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.5.4 AstraZeneca Diabetes Medicines Products Offered
        10.5.5 AstraZeneca Recent Development
    10.6 bayer
        10.6.1 bayer Company Information
        10.6.2 bayer Description and Business Overview
        10.6.3 bayer Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.6.4 bayer Diabetes Medicines Products Offered
        10.6.5 bayer Recent Development
    10.7 Boehringer Ingelheim
        10.7.1 Boehringer Ingelheim Company Information
        10.7.2 Boehringer Ingelheim Description and Business Overview
        10.7.3 Boehringer Ingelheim Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.7.4 Boehringer Ingelheim Diabetes Medicines Products Offered
        10.7.5 Boehringer Ingelheim Recent Development
    10.8 Johnson & Johnson
        10.8.1 Johnson & Johnson Company Information
        10.8.2 Johnson & Johnson Description and Business Overview
        10.8.3 Johnson & Johnson Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.8.4 Johnson & Johnson Diabetes Medicines Products Offered
        10.8.5 Johnson & Johnson Recent Development
    10.9 Takeda
        10.9.1 Takeda Company Information
        10.9.2 Takeda Description and Business Overview
        10.9.3 Takeda Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.9.4 Takeda Diabetes Medicines Products Offered
        10.9.5 Takeda Recent Development
    10.10 Tonghua Dongbao
        10.10.1 Tonghua Dongbao Company Information
        10.10.2 Tonghua Dongbao Description and Business Overview
        10.10.3 Tonghua Dongbao Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.10.4 Tonghua Dongbao Diabetes Medicines Products Offered
        10.10.5 Tonghua Dongbao Recent Development
    10.11 United Pharmaceuticals
        10.11.1 United Pharmaceuticals Company Information
        10.11.2 United Pharmaceuticals Description and Business Overview
        10.11.3 United Pharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.11.4 United Pharmaceuticals Diabetes Medicines Products Offered
        10.11.5 United Pharmaceuticals Recent Development
    10.12 Ganli Pharmaceutical
        10.12.1 Ganli Pharmaceutical Company Information
        10.12.2 Ganli Pharmaceutical Description and Business Overview
        10.12.3 Ganli Pharmaceutical Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.12.4 Ganli Pharmaceutical Diabetes Medicines Products Offered
        10.12.5 Ganli Pharmaceutical Recent Development
    10.13 Biocon
        10.13.1 Biocon Company Information
        10.13.2 Biocon Description and Business Overview
        10.13.3 Biocon Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.13.4 Biocon Diabetes Medicines Products Offered
        10.13.5 Biocon Recent Development
    10.14 Conker Pharmaceuticals
        10.14.1 Conker Pharmaceuticals Company Information
        10.14.2 Conker Pharmaceuticals Description and Business Overview
        10.14.3 Conker Pharmaceuticals Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.14.4 Conker Pharmaceuticals Diabetes Medicines Products Offered
        10.14.5 Conker Pharmaceuticals Recent Development
    10.15 Jiangsu Wanbang
        10.15.1 Jiangsu Wanbang Company Information
        10.15.2 Jiangsu Wanbang Description and Business Overview
        10.15.3 Jiangsu Wanbang Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.15.4 Jiangsu Wanbang Diabetes Medicines Products Offered
        10.15.5 Jiangsu Wanbang Recent Development
    10.16 Geropharm
        10.16.1 Geropharm Company Information
        10.16.2 Geropharm Description and Business Overview
        10.16.3 Geropharm Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.16.4 Geropharm Diabetes Medicines Products Offered
        10.16.5 Geropharm Recent Development
    10.17 Wockhardt
        10.17.1 Wockhardt Company Information
        10.17.2 Wockhardt Description and Business Overview
        10.17.3 Wockhardt Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.17.4 Wockhardt Diabetes Medicines Products Offered
        10.17.5 Wockhardt Recent Development
    10.18 Merck Serono
        10.18.1 Merck Serono Company Information
        10.18.2 Merck Serono Description and Business Overview
        10.18.3 Merck Serono Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.18.4 Merck Serono Diabetes Medicines Products Offered
        10.18.5 Merck Serono Recent Development
    10.19 Novartis
        10.19.1 Novartis Company Information
        10.19.2 Novartis Description and Business Overview
        10.19.3 Novartis Diabetes Medicines Sales, Revenue and Gross Margin (2019-2024)
        10.19.4 Novartis Diabetes Medicines Products Offered
        10.19.5 Novartis Recent Development

 11 Industry Chain and Sales Channels Analysis
    11.1 Diabetes Medicines Industry Chain Analysis
    11.2 Diabetes Medicines Key Raw Materials
        11.2.1 Key Raw Materials
        11.2.2 Raw Materials Key Suppliers
    11.3 Diabetes Medicines Production Mode & Process
    11.4 Diabetes Medicines Sales and Marketing
        11.4.1 Diabetes Medicines Sales Channels
        11.4.2 Diabetes Medicines Distributors
    11.5 Diabetes Medicines Customers

 12 Research Findings and Conclusion

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
            13.1.1.1 Research Programs/Design
            13.1.1.2 Market Size Estimation
            13.1.1.3 Market Breakdown and Data Triangulation
        13.1.2 Data Source
            13.1.2.1 Secondary Sources
            13.1.2.2 Primary Sources
    13.2 Author Details
    13.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Diabetes Medicines CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030
 Table 2. Diabetes Medicines Market Trends
 Table 3. Diabetes Medicines Market Drivers
 Table 4. Diabetes Medicines Market Challenges
 Table 5. Diabetes Medicines Market Restraints
 Table 6. Global Diabetes Medicines Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 7. United States Diabetes Medicines Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Diabetes Medicines Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. United States Diabetes Medicines Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 10. Global Key Manufacturers of Diabetes Medicines, Ranked by Revenue (2023) & (US$ Million)
 Table 11. Global Diabetes Medicines Revenue by Manufacturer, (US$ Million) & (2019-2024)
 Table 12. Global Diabetes Medicines Revenue Share by Manufacturer, 2019-2024
 Table 13. Global Diabetes Medicines Sales by Manufacturer, (K Units), 2019-2024
 Table 14. Global Diabetes Medicines Sales Share by Manufacturer, 2019-2024
 Table 15. Global Diabetes Medicines Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 16. Global Diabetes Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 17. Global Diabetes Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Medicines as of 2023)
 Table 18. Global Key Manufacturers of Diabetes Medicines, Manufacturing Base Distribution and Headquarters
 Table 19. Global Key Manufacturers of Diabetes Medicines, Product Offered and Application
 Table 20. Global Key Manufacturers of Diabetes Medicines, Date of Enter into This Industry
 Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 22. Key Players of Diabetes Medicines in United States, Ranked by Revenue (2023) & (US$ million)
 Table 23. United States Diabetes Medicines Revenue by Players, (US$ Million) & (2019-2024)
 Table 24. United States Diabetes Medicines Revenue Share by Players, (2019-2024)
 Table 25. United States Diabetes Medicines Sales by Players, (K Units) & (2019-2024)
 Table 26. United States Diabetes Medicines Sales Share by Players, (2019-2024)
 Table 27. Global Diabetes Medicines Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 28. Global Diabetes Medicines Sales in Volume by Region (2019-2024) & (K Units)
 Table 29. Global Diabetes Medicines Sales in Volume Forecast by Region (2025-2030) & (K Units)
 Table 30. Global Diabetes Medicines Sales in Value by Region (2019-2024) & (US$ Million)
 Table 31. Global Diabetes Medicines Sales in Value Forecast by Region (2025-2030) & (US$ Million)
 Table 32. Americas Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 33. Americas Diabetes Medicines Sales in Value by Country (2019-2024) & (US$ Million)
 Table 34. Americas Diabetes Medicines Sales in Value by Country (2025-2030) & (US$ Million)
 Table 35. Americas Diabetes Medicines Sales in Volume by Country (2019-2024) & (K Units)
 Table 36. Americas Diabetes Medicines Sales in Volume by Country (2025-2030) & (K Units)
 Table 37. EMEA Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. EMEA Diabetes Medicines Sales in Value by Country (2019-2024) & (US$ Million)
 Table 39. EMEA Diabetes Medicines Sales in Value by Country (2025-2030) & (US$ Million)
 Table 40. EMEA Diabetes Medicines Sales in Volume by Country (2019-2024) & (K Units)
 Table 41. EMEA Diabetes Medicines Sales in Volume by Country (2025-2030) & (K Units)
 Table 42. APAC Diabetes Medicines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. APAC Diabetes Medicines Sales in Value by Country (2019-2024) & (US$ Million)
 Table 44. APAC Diabetes Medicines Sales in Value by Country (2025-2030) & (US$ Million)
 Table 45. APAC Diabetes Medicines Sales in Volume by Country (2019-2024) & (K Units)
 Table 46. APAC Diabetes Medicines Sales in Volume by Country (2025-2030) & (K Units)
 Table 47. Novo Nordisk Company Information
 Table 48. Novo Nordisk Description and Business Overview
 Table 49. Novo Nordisk Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 50. Novo Nordisk Diabetes Medicines Product
 Table 51. Novo Nordisk Recent Development
 Table 52. Sanofi Company Information
 Table 53. Sanofi Description and Business Overview
 Table 54. Sanofi Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 55. Sanofi Diabetes Medicines Product
 Table 56. Sanofi Recent Development
 Table 57. Eli Lilly Company Information
 Table 58. Eli Lilly Description and Business Overview
 Table 59. Eli Lilly Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 60. Eli Lilly Diabetes Medicines Product
 Table 61. Eli Lilly Recent Development
 Table 62. Merck Company Information
 Table 63. Merck Description and Business Overview
 Table 64. Merck Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 65. Merck Diabetes Medicines Product
 Table 66. Merck Recent Development
 Table 67. AstraZeneca Company Information
 Table 68. AstraZeneca Description and Business Overview
 Table 69. AstraZeneca Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 70. AstraZeneca Diabetes Medicines Product
 Table 71. AstraZeneca Recent Development
 Table 72. bayer Company Information
 Table 73. bayer Description and Business Overview
 Table 74. bayer Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 75. bayer Diabetes Medicines Product
 Table 76. bayer Recent Development
 Table 77. Boehringer Ingelheim Company Information
 Table 78. Boehringer Ingelheim Description and Business Overview
 Table 79. Boehringer Ingelheim Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 80. Boehringer Ingelheim Diabetes Medicines Product
 Table 81. Boehringer Ingelheim Recent Development
 Table 82. Johnson & Johnson Company Information
 Table 83. Johnson & Johnson Description and Business Overview
 Table 84. Johnson & Johnson Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 85. Johnson & Johnson Diabetes Medicines Product
 Table 86. Johnson & Johnson Recent Development
 Table 87. Takeda Company Information
 Table 88. Takeda Description and Business Overview
 Table 89. Takeda Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 90. Takeda Diabetes Medicines Product
 Table 91. Takeda Recent Development
 Table 92. Tonghua Dongbao Company Information
 Table 93. Tonghua Dongbao Description and Business Overview
 Table 94. Tonghua Dongbao Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 95. Tonghua Dongbao Diabetes Medicines Product
 Table 96. Tonghua Dongbao Recent Development
 Table 97. United Pharmaceuticals Company Information
 Table 98. United Pharmaceuticals Description and Business Overview
 Table 99. United Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 100. United Pharmaceuticals Diabetes Medicines Product
 Table 101. United Pharmaceuticals Recent Development
 Table 102. Ganli Pharmaceutical Company Information
 Table 103. Ganli Pharmaceutical Description and Business Overview
 Table 104. Ganli Pharmaceutical Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 105. Ganli Pharmaceutical Diabetes Medicines Product
 Table 106. Ganli Pharmaceutical Recent Development
 Table 107. Biocon Company Information
 Table 108. Biocon Description and Business Overview
 Table 109. Biocon Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. Biocon Diabetes Medicines Product
 Table 111. Biocon Recent Development
 Table 112. Conker Pharmaceuticals Company Information
 Table 113. Conker Pharmaceuticals Description and Business Overview
 Table 114. Conker Pharmaceuticals Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Conker Pharmaceuticals Diabetes Medicines Product
 Table 116. Conker Pharmaceuticals Recent Development
 Table 117. Jiangsu Wanbang Company Information
 Table 118. Jiangsu Wanbang Description and Business Overview
 Table 119. Jiangsu Wanbang Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Jiangsu Wanbang Diabetes Medicines Product
 Table 121. Jiangsu Wanbang Recent Development
 Table 122. Geropharm Company Information
 Table 123. Geropharm Description and Business Overview
 Table 124. Geropharm Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Geropharm Diabetes Medicines Product
 Table 126. Geropharm Recent Development
 Table 127. Wockhardt Company Information
 Table 128. Wockhardt Description and Business Overview
 Table 129. Wockhardt Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. Wockhardt Diabetes Medicines Product
 Table 131. Wockhardt Recent Development
 Table 132. Merck Serono Company Information
 Table 133. Merck Serono Description and Business Overview
 Table 134. Merck Serono Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. Merck Serono Diabetes Medicines Product
 Table 136. Merck Serono Recent Development
 Table 137. Novartis Company Information
 Table 138. Novartis Description and Business Overview
 Table 139. Novartis Diabetes Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. Novartis Diabetes Medicines Product
 Table 141. Novartis Recent Development
 Table 142. Key Raw Materials Lists
 Table 143. Raw Materials Key Suppliers Lists
 Table 144. Diabetes Medicines Distributors List
 Table 145. Diabetes Medicines Customers List
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources


List of Figures
 Figure 1. Diabetes Medicines Product Picture
 Figure 2. Global Diabetes Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 3. Global Diabetes Medicines Market Size 2019-2030 (US$ Million)
 Figure 4. Global Diabetes Medicines Sales 2019-2030 (K Units)
 Figure 5. United States Diabetes Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 6. United States Diabetes Medicines Market Size 2019-2030 (US$ Million)
 Figure 7. United States Diabetes Medicines Sales 2019-2030 (K Units)
 Figure 8. United States Diabetes Medicines Market Share in Global, in Value (US$ Million) 2019-2030
 Figure 9. United States Diabetes Medicines Market Share in Global, in Volume (K Units) 2019-2030
 Figure 10. Diabetes Medicines Report Years Considered
 Figure 11. Product Picture of Oral
 Figure 12. Product Picture of Injection
 Figure 13. Global Diabetes Medicines Market Share by Type in 2023 & 2030
 Figure 14. Global Diabetes Medicines Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 15. Global Diabetes Medicines Sales Market Share in Value by Type (2019-2030)
 Figure 16. Global Diabetes Medicines Sales by Type (2019-2030) & (K Units)
 Figure 17. Global Diabetes Medicines Sales Market Share in Volume by Type (2019-2030)
 Figure 18. Global Diabetes Medicines Price by Type (2019-2030) & (US$/Unit)
 Figure 19. United States Diabetes Medicines Market Share by Type in 2023 & 2030
 Figure 20. United States Diabetes Medicines Sales in Value by Type (2019-2030) & (US$ Million)
 Figure 21. United States Diabetes Medicines Sales Market Share in Value by Type (2019-2030)
 Figure 22. United States Diabetes Medicines Sales by Type (2019-2030) & (K Units)
 Figure 23. United States Diabetes Medicines Sales Market Share in Volume by Type (2019-2030)
 Figure 24. United States Diabetes Medicines Price by Type (2019-2030) & (US$/Unit)
 Figure 25. Product Picture of Hospital
 Figure 26. Product Picture of Retail Pharmacy
 Figure 27. Global Diabetes Medicines Market Share by Application in 2023 & 2030
 Figure 28. Global Diabetes Medicines Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 29. Global Diabetes Medicines Sales Market Share in Value by Application (2019-2030)
 Figure 30. Global Diabetes Medicines Sales by Application (2019-2030) & (K Units)
 Figure 31. Global Diabetes Medicines Sales Market Share in Volume by Application (2019-2030)
 Figure 32. Global Diabetes Medicines Price by Application (2019-2030) & (US$/Unit)
 Figure 33. United States Diabetes Medicines Market Share by Application in 2023 & 2030
 Figure 34. United States Diabetes Medicines Sales in Value by Application (2019-2030) & (US$ Million)
 Figure 35. United States Diabetes Medicines Sales Market Share in Value by Application (2019-2030)
 Figure 36. United States Diabetes Medicines Sales by Application (2019-2030) & (K Units)
 Figure 37. United States Diabetes Medicines Sales Market Share in Volume by Application (2019-2030)
 Figure 38. United States Diabetes Medicines Price by Application (2019-2030) & (US$/Unit)
 Figure 39. The Top 5 and 10 Largest Manufacturers of Diabetes Medicines in the World: Market Share by Diabetes Medicines Revenue in 2023
 Figure 40. Global Diabetes Medicines Market Size Market Share by Region: 2019 VS 2023 VS 2030
 Figure 41. Global Diabetes Medicines Sales in Volume Market Share by Region (2019-2030)
 Figure 42. Global Diabetes Medicines Sales in Value Market Share by Region (2019-2030)
 Figure 43. Americas Diabetes Medicines Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 44. Americas Diabetes Medicines Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 45. Americas Diabetes Medicines Sales by Type (2019-2030) & (K Units)
 Figure 46. Americas Diabetes Medicines Sales Market Share in Volume by Type (2019-2030)
 Figure 47. Americas Diabetes Medicines Sales by Application (2019-2030) & (K Units)
 Figure 48. Americas Diabetes Medicines Sales Market Share in Volume by Application (2019-2030)
 Figure 49. United States Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Canada Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Mexico Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Brazil Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 53. EMEA Diabetes Medicines Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 54. EMEA Diabetes Medicines Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 55. EMEA Diabetes Medicines Sales by Type (2019-2030) & (K Units)
 Figure 56. EMEA Diabetes Medicines Sales Market Share in Volume by Type (2019-2030)
 Figure 57. EMEA Diabetes Medicines Sales by Application (2019-2030) & (K Units)
 Figure 58. EMEA Diabetes Medicines Sales Market Share in Volume by Application (2019-2030)
 Figure 59. Europe Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 60. Middle East Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 61. Africa Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 62. China Diabetes Medicines Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 63. China Diabetes Medicines Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 64. China Diabetes Medicines Sales by Type (2019-2030) & (K Units)
 Figure 65. China Diabetes Medicines Sales Market Share in Volume by Type (2019-2030)
 Figure 66. China Diabetes Medicines Sales by Application (2019-2030) & (K Units)
 Figure 67. China Diabetes Medicines Sales Market Share in Volume by Application (2019-2030)
 Figure 68. APAC Diabetes Medicines Sales in Volume Growth Rate 2019-2030 (K Units)
 Figure 69. APAC Diabetes Medicines Sales in Value Growth Rate 2019-2030 (US$ Million)
 Figure 70. APAC Diabetes Medicines Sales by Type (2019-2030) & (K Units)
 Figure 71. APAC Diabetes Medicines Sales Market Share in Volume by Type (2019-2030)
 Figure 72. APAC Diabetes Medicines Sales by Application (2019-2030) & (K Units)
 Figure 73. APAC Diabetes Medicines Sales Market Share in Volume by Application (2019-2030)
 Figure 74. Japan Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 75. South Korea Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 76. China Taiwan Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 77. Southeast Asia Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 78. India Diabetes Medicines Sales in Value Growth Rate (2019-2030) & (US$ Million)
 Figure 79. Diabetes Medicines Value Chain
 Figure 80. Diabetes Medicines Production Process
 Figure 81. Channels of Distribution (Direct Vs Distribution)
 Figure 82. Bottom-up and Top-down Approaches for This Report
 Figure 83. Data Triangulation
 Figure 84. Key Executives Interviewed

Description

Diabetes Medicines are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.

The global Diabetes Medicines revenue was US$ 97410 million in 2023 and is forecast to a readjusted size of US$ 207020 million by 2030 with a CAGR of 11.2% during the review period (2024-2030).

In United States the Diabetes Medicines revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).

This report focuses on global and United States Diabetes Medicines market, also covers the segmentation data of other regions in regional level and county level.

Global Diabetes Medicines key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 62%. 
In terms of product type, Injection is the largest segment, with a share of 60%. And in terms of application, Hospital has a share about 67 percent.

Diabetes Medicines market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Diabetes Medicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.

For United States market, this report focuses on the Diabetes Medicines market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.

Market Segmentation